To investigate serum level of interleukin-17 in rheumatoid arthritis patients and to assess the relationship of this cytokine with serum levels of IL-6 and tumor necrosis factor α. Subjects and methods: 82 patients with rheumatoid arthritis and 30 healthy volunteers were enrolled in the study. Disease activity was determined by disease activity score (DAS28) in patients with rheumatoid arthritis. | Serum level of interleukin-17 and its relation to interleukin-6 and tumor necrosis factor alpha level in patients with rheumatoid arthritis
